Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis
Journal
Lung Cancer
Journal Volume
154
Pages
113-117
Date Issued
2021
Author(s)
Abstract
Objectives: To assess the clinical utility of quantitative PCR (qPCR) assays, a routinely used test for detection of epidermal growth factor receptor (EGFR) mutation in circulating tumour DNA (ctDNA) in treatment-naive advanced lung cancer patients. Mater
Subjects
Circulating tumor DNA; ctDNA; EGFR; False negative; Quantitative PCR
SDGs
Other Subjects
circulating tumor DNA; epidermal growth factor receptor; epidermal growth factor receptor kinase inhibitor; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; tumor marker; advanced cancer; Article; cancer chemotherapy; cance
Publisher
Elsevier Ireland Ltd
Type
journal article